The deal priced at midpoint of $54.00-$56.00 target range. Morgan Stanley, Goldman Sachs, TD Cowen and Piper Sandler are acting as joint book running managers for the offering.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on NTRA:
- Natera $250M Spot Secondary; price range $54.00-$56.00
- Natera announces $250M common stock offering
- Natera: Prospera lung transplant assessment test granted Medicare coverage
- Natera price target raised to $80 from $70 at Piper Sandler
- CareDx says district court judge issues injunction against Natera